Home › Attention Deficit Hyperactivity Disorder › Alabama
Attention Deficit Hyperactivity Disorder clinical trials in Alabama
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Alabama.
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- The Center for Clinical Trials, Inc., Saraland
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Dothan
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Dothan
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Aug 19, 2026 · NCT05776056From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.